BioPhorum Drug Substance (DS) member companies recognize the importance of visible senior sponsorship when it comes to workstreams that require co-implementation in order to fully realize the benefits of adopting standardized industry approaches. The table below shows four DS workstreams that depend on co-implementation together with the names of the member companies and senior sponsors who are intending to start implementation of one or more of these workstreams in 2019.
The purpose of this statement is to help build momentum within the industry and to that end other companies’ senior sponsors’ names will be added to this table as they fully develop their implementation plans.
In 2019 the following companies are intending to start joint implementation of the BioPhorum workstreams as highlighted in the table below.
The named senior sponsors will ensure strategic alignment and appropriate functional support within their companies.